CVS Health Debt to Equity Ratio 2011-2025 | CVS
Current and historical debt to equity ratio values for CVS Health (CVS) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. CVS Health debt/equity for the three months ending September 30, 2025 was 0.83.
| CVS Health Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2025-09-30 | $182.22B | $73.11B | 2.49 |
| 2025-06-30 | $180.79B | $77.55B | 2.33 |
| 2025-03-31 | $178.48B | $77.11B | 2.32 |
| 2024-12-31 | $177.49B | $75.73B | 2.34 |
| 2024-09-30 | $177.32B | $75.11B | 2.36 |
| 2024-06-30 | $177.37B | $75.11B | 2.36 |
| 2024-03-31 | $175.59B | $74.15B | 2.37 |
| 2023-12-31 | $173.09B | $76.64B | 2.26 |
| 2023-09-30 | $176.80B | $74.51B | 2.37 |
| 2023-06-30 | $177.07B | $73.00B | 2.43 |
| 2023-03-31 | $167.75B | $71.58B | 2.34 |
| 2022-12-31 | $156.51B | $71.77B | 2.18 |
| 2022-09-30 | $160.20B | $71.01B | 2.26 |
| 2022-06-30 | $154.77B | $75.51B | 2.05 |
| 2022-03-31 | $158.73B | $74.14B | 2.14 |
| 2021-12-31 | $157.62B | $75.38B | 2.09 |
| 2021-09-30 | $160.27B | $74.62B | 2.15 |
| 2021-06-30 | $157.60B | $73.57B | 2.14 |
| 2021-03-31 | $158.44B | $71.16B | 2.23 |
| 2020-12-31 | $161.01B | $69.70B | 2.31 |
| 2020-09-30 | $163.79B | $69.11B | 2.37 |
| 2020-06-30 | $167.14B | $68.36B | 2.45 |
| 2020-03-31 | $165.17B | $65.47B | 2.52 |
| 2019-12-31 | $158.28B | $64.17B | 2.47 |
| 2019-09-30 | $157.18B | $62.93B | 2.50 |
| 2019-06-30 | $157.31B | $61.60B | 2.55 |
| 2019-03-31 | $159.76B | $60.01B | 2.66 |
| 2018-12-31 | $137.91B | $58.54B | 2.36 |
| 2018-09-30 | $94.88B | $36.62B | 2.59 |
| 2018-06-30 | $97.68B | $35.61B | 2.74 |
| 2018-03-31 | $96.46B | $38.68B | 2.49 |
| 2017-12-31 | $57.44B | $37.70B | 1.52 |
| 2017-09-30 | $57.99B | $34.87B | 1.66 |
| 2017-06-30 | $58.38B | $34.15B | 1.71 |
| 2017-03-31 | $58.83B | $33.84B | 1.74 |
| 2016-12-31 | $57.63B | $36.83B | 1.57 |
| 2016-09-30 | $58.20B | $35.95B | 1.62 |
| 2016-06-30 | $57.98B | $34.77B | 1.67 |
| 2016-03-31 | $56.60B | $36.03B | 1.57 |
| 2015-12-31 | $55.23B | $37.20B | 1.49 |
| 2015-09-30 | $55.18B | $37.18B | 1.48 |
| 2015-06-30 | $37.54B | $37.13B | 1.01 |
| 2015-03-31 | $36.94B | $37.00B | 1.00 |
| 2014-12-31 | $36.22B | $37.96B | 0.95 |
| 2014-09-30 | $35.47B | $38.11B | 0.93 |
| 2014-06-30 | $34.46B | $38.13B | 0.90 |
| 2014-03-31 | $34.61B | $38.21B | 0.91 |
| 2013-12-31 | $33.59B | $37.94B | 0.89 |
| 2013-09-30 | $29.27B | $38.53B | 0.76 |
| 2013-06-30 | $27.38B | $38.91B | 0.70 |
| 2013-03-31 | $27.86B | $38.21B | 0.73 |
| 2012-12-31 | $28.57B | $37.65B | 0.76 |
| 2012-09-30 | $27.88B | $36.92B | 0.76 |
| 2012-06-30 | $27.68B | $37.91B | 0.73 |
| 2012-03-31 | $27.95B | $38.05B | 0.74 |
| 2011-12-31 | $26.49B | $38.05B | 0.70 |
| 2011-09-30 | $27.76B | $37.49B | 0.74 |
| 2011-06-30 | $27.24B | $38.24B | 0.71 |
| 2011-03-31 | $24.91B | $37.92B | 0.66 |
| 2010-12-31 | $24.47B | $37.70B | 0.65 |
| 2010-09-30 | $25.08B | $36.64B | 0.68 |
| 2010-06-30 | $25.65B | $35.87B | 0.72 |
| 2010-03-31 | $25.59B | $35.69B | 0.72 |
| 2009-12-31 | $25.87B | $35.77B | 0.72 |
| 2009-09-30 | $26.20B | $35.68B | 0.74 |
| 2009-06-30 | $24.88B | $36.15B | 0.69 |
| 2009-03-31 | $25.37B | $35.29B | 0.72 |
| 2008-12-31 | $26.39B | $34.57B | 0.76 |
| 2008-09-30 | $22.22B | $33.74B | 0.66 |
| 2008-06-30 | $21.46B | $33.01B | 0.65 |
| 2008-03-31 | $22.42B | $32.15B | 0.70 |
| 2007-12-31 | $23.40B | $31.32B | 0.75 |
| 2007-09-30 | $22.11B | $32.79B | 0.67 |
| 2007-06-30 | $22.58B | $32.03B | 0.71 |
| 2007-03-31 | $17.00B | $34.03B | 0.50 |
| 2006-12-31 | $10.66B | $9.92B | 1.08 |
| 2006-09-30 | $11.69B | $9.43B | 1.24 |
| 2006-06-30 | $11.22B | $9.08B | 1.24 |
| 2006-03-31 | $6.73B | $8.72B | 0.77 |
| 2005-12-31 | $6.95B | $8.33B | 0.83 |
| 2005-09-30 | $7.27B | $7.96B | 0.91 |
| 2005-06-30 | $7.08B | $7.68B | 0.92 |
| 2005-03-31 | $7.42B | $7.40B | 1.00 |
| 2004-12-31 | $7.56B | $6.99B | 1.08 |
| 2004-09-30 | $7.63B | $6.71B | 1.14 |
| 2004-06-30 | $3.99B | $6.53B | 0.61 |
| 2004-03-31 | $4.08B | $6.28B | 0.65 |
| 2003-12-31 | $4.52B | $6.02B | 0.75 |
| 2003-09-30 | $4.41B | $5.74B | 0.77 |
| 2003-06-30 | $4.06B | $5.56B | 0.73 |
| 2003-03-31 | $4.29B | $5.38B | 0.80 |
| 2002-12-31 | $4.45B | $5.20B | 0.86 |
| 2002-09-30 | $4.00B | $5.05B | 0.79 |
| 2002-06-30 | $4.10B | $4.89B | 0.84 |
| 2002-03-31 | $4.48B | $4.74B | 0.95 |
| 2001-12-31 | $4.07B | $4.57B | 0.89 |
| 2001-09-30 | $4.23B | $4.71B | 0.90 |
| 2001-06-30 | $3.85B | $4.73B | 0.81 |
| 2001-03-31 | $3.84B | $4.54B | 0.85 |
| 2000-12-31 | $3.65B | $4.31B | 0.85 |
| 2000-09-30 | $4.04B | $4.08B | 0.99 |
| 2000-06-30 | $3.74B | $3.93B | 0.95 |
| 2000-03-31 | $3.94B | $3.75B | 1.05 |
| 1999-12-31 | $3.60B | $3.68B | 0.98 |
| 1999-09-30 | $3.66B | $3.51B | 1.04 |
| 1999-06-30 | $3.48B | $3.41B | 1.02 |
| 1999-03-31 | $3.58B | $3.26B | 1.10 |
| 1998-12-31 | $3.63B | $3.11B | 1.17 |
| 1998-09-30 | $3.54B | $2.97B | 1.19 |
| 1998-06-30 | $3.21B | $2.86B | 1.12 |
| 1998-03-31 | $3.32B | $2.48B | 1.34 |
| 1997-12-31 | $3.28B | $2.36B | 1.39 |
| 1997-09-30 | $3.12B | $2.24B | 1.40 |
| 1997-06-30 | $3.16B | $2.15B | 1.47 |
| 1997-03-31 | $1.45B | $1.31B | 1.10 |
| 1996-12-31 | $1.59B | $1.25B | 1.27 |
| 1996-09-30 | $1.94B | $1.56B | 1.24 |
| 1996-06-30 | $1.89B | $1.51B | 1.25 |
| 1996-03-31 | $2.48B | $1.57B | 1.58 |
| 1995-12-31 | $2.41B | $1.55B | 1.56 |
| 1995-09-30 | $3.00B | $2.25B | 1.33 |
| 1995-06-30 | $2.56B | $2.29B | 1.12 |
| 1995-03-31 | $2.62B | $2.29B | 1.14 |
| 1994-12-31 | $2.35B | $2.38B | 0.99 |
| 1994-09-30 | $2.71B | $2.23B | 1.22 |
| 1994-06-30 | $2.19B | $2.21B | 0.99 |
| 1994-03-31 | $2.16B | $2.21B | 0.98 |
| 1993-12-31 | $2.02B | $2.25B | 0.90 |
| 1993-09-30 | $2.41B | $2.06B | 1.17 |
| 1993-06-30 | $2.07B | $2.06B | 1.01 |
| 1993-03-31 | $2.16B | $2.02B | 1.07 |
| 1992-12-31 | $2.04B | $2.08B | 0.98 |
| 1992-09-30 | $2.44B | $2.11B | 1.16 |
| 1992-06-30 | $2.18B | $2.09B | 1.05 |
| 1992-03-31 | $2.23B | $2.04B | 1.09 |
| 1991-12-31 | $1.89B | $2.09B | 0.90 |
| 1991-09-30 | $2.28B | $1.87B | 1.22 |
| 1991-06-30 | $2.06B | $1.85B | 1.12 |
| 1991-03-31 | $2.08B | $1.82B | 1.15 |
| 1990-12-31 | $1.70B | $1.85B | 0.92 |
| 1990-09-30 | $2.32B | $1.67B | 1.39 |
| 1990-06-30 | $1.45B | $1.64B | 0.88 |
| 1990-03-31 | $1.51B | $1.60B | 0.94 |
| 1989-12-31 | $1.41B | $1.62B | 0.87 |
| 1989-09-30 | $1.56B | $1.56B | 1.00 |
| 1989-06-30 | $1.19B | $1.72B | 0.69 |
| 1989-03-31 | $0.98B | $1.71B | 0.58 |
| 1988-12-31 | $0.93B | $1.71B | 0.55 |
| 1988-09-30 | $0.92B | $1.53B | 0.60 |
| 1988-06-30 | $0.68B | $1.49B | 0.46 |
| 1988-03-31 | $0.73B | $1.46B | 0.50 |
| 1987-12-31 | $0.68B | $1.46B | 0.47 |
| 1987-09-30 | $0.81B | $1.32B | 0.61 |
| 1987-06-30 | $0.62B | $1.29B | 0.48 |
| 1987-03-31 | $0.66B | $1.25B | 0.53 |
| 1986-12-31 | $0.65B | $1.27B | 0.51 |
| 1985-12-31 | $0.62B | $1.11B | 0.56 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $100.272B | $372.809B |
| CVS Health Corporation is a pharmacy innovation company. Its offerings include pharmacy benefit management services, mail order, retail and specialty pharmacy, disease management programs, and retail clinics. The Company serves employers, insurance companies, unions, government employee groups, managed care organizations and other sponsors of health benefit plans, and individuals under the CVS Caremark Pharmacy Services, Caremark, CVS Caremark, CarePlus CVS/pharmacy, RxAmerica, Accordant, SilverScript, and Novologix names. CVS Health Corporation, formerly known as CVS Caremark Corporation, is headquartered in Woonsocket, Rhode Island. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $148.291B | 27.23 |
| HCA Healthcare (HCA) | United States | $108.760B | 18.01 |
| Elevance Health (ELV) | United States | $70.623B | 10.36 |
| Cencora (COR) | United States | $69.932B | 22.56 |
| Natera (NTRA) | United States | $27.391B | 0.00 |
| DiDi Global (DIDIY) | China | $25.980B | 21.23 |
| Labcorp Holdings (LH) | United States | $20.950B | 15.97 |
| Medpace Holdings (MEDP) | United States | $16.595B | 41.20 |
| BioMerieux (BMXMF) | France | $15.266B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $13.557B | 0.00 |
| ICON (ICLR) | Ireland | $12.852B | 12.75 |
| Solventum (SOLV) | United States | $12.401B | 12.04 |
| CochLear (CHEOY) | Australia | $12.093B | 0.00 |
| Viatris (VTRS) | United States | $11.683B | 4.34 |
| Revvity (RVTY) | United States | $10.292B | 18.95 |
| Charles River Laboratories (CRL) | United States | $8.271B | 15.93 |
| HealthEquity (HQY) | United States | $8.074B | 32.31 |
| Avantor (AVTR) | United States | $7.875B | 12.03 |
| Caris Life Sciences,�Inc (CAI) | United States | $7.226B | 0.00 |
| Sonic Healthcare (SKHHY) | Australia | $6.746B | 0.00 |
| BrightSpring Health Services (BTSG) | United States | $5.977B | 35.63 |
| Bausch + Lomb (BLCO) | Canada | $5.508B | 36.16 |
| Sotera Health (SHC) | United States | $4.455B | 21.48 |
| Amplifon S.p.A (AMFPF) | Italy | $4.059B | 23.68 |
| GeneDx Holdings (WGS) | United States | $4.014B | 70.93 |
| Alignment Healthcare (ALHC) | United States | $3.268B | 0.00 |
| Surgery Partners (SGRY) | United States | $2.756B | 34.68 |
| Concentras Parent (CON) | United States | $2.479B | 15.47 |
| Premier (PINC) | United States | $2.324B | 22.52 |
| Ardent Health (ARDT) | United States | $2.061B | 7.96 |
| Progyny (PGNY) | United States | $1.923B | 37.92 |
| Pediatrix Medical (MD) | United States | $1.883B | 11.25 |
| Establishment Labs Holdings (ESTA) | $1.883B | 0.00 | |
| PACS (PACS) | United States | $1.878B | 0.00 |
| Organon (OGN) | United States | $1.763B | 1.92 |
| Teladoc Health (TDOC) | United States | $1.336B | 0.00 |
| Omada Health (OMDA) | $1.169B | 0.00 | |
| GoodRx Holdings (GDRX) | United States | $1.081B | 17.28 |
| Embecta (EMBC) | United States | $0.807B | 4.72 |
| CareDx (CDNA) | United States | $0.803B | 13.13 |
| InnovAge Holding (INNV) | United States | $0.718B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.685B | 9.46 |
| Nutex Health (NUTX) | United States | $0.637B | 9.64 |
| Sonida Senior Living (SNDA) | United States | $0.604B | 0.00 |
| Pomdoctor - (POM) | China | $0.540B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.523B | 0.00 |
| So-Young (SY) | China | $0.449B | 0.00 |
| CryoPort (CYRX) | United States | $0.420B | 0.00 |
| Enhabit (EHAB) | United States | $0.402B | 18.07 |
| Auna S.A (AUNA) | Luxembourg | $0.401B | 6.02 |
| Charming Medical (MCTA) | $0.374B | 0.00 | |
| Strata Critical Medical (SRTA) | United States | $0.362B | 0.00 |
| KindlyMD (NAKA) | United States | $0.339B | 0.00 |
| Oncology Institute (TOI) | United States | $0.331B | 0.00 |
| SBC Medicals (SBC) | United States | $0.327B | 7.16 |
| Agilon Health (AGL) | United States | $0.277B | 0.00 |
| LifeMD (LFMD) | United States | $0.248B | 0.00 |
| Shoulder Innovations (SI) | United States | $0.225B | 0.00 |
| Beauty Health (SKIN) | United States | $0.178B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.157B | 26.99 |
| Ascend Wellness Holdings (AAWH) | United States | $0.124B | 0.00 |
| DocGo (DCGO) | United States | $0.109B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.095B | 0.00 |
| Biodesix (BDSX) | United States | $0.062B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.047B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.035B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.026B | 0.00 |
| Synergy CHC (SNYR) | United States | $0.021B | 5.89 |
| Co-Diagnostics (CODX) | United States | $0.020B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.017B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.013B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.009B | 0.00 | |
| Intelligent Bio Solutions (INBS) | United States | $0.007B | 0.00 |
| ISpecimen (ISPC) | United States | $0.006B | 0.00 |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.004B | 0.00 |
| INVO Fertility (IVF) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |